---
schema_version: "secwatch.filing_event.v1"
accession: "0000105770-24-000088"
form_type: "8-K"
ticker: "WST"
cik: "0000105770"
company_name: "WEST PHARMACEUTICAL SERVICES INC"
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:18:12.083366+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# West Pharmaceutical authorizes repurchase of up to 550,000 shares

## Summary
- Board approved new share repurchase program on Dec 9, 2024, authorizing up to 550,000 shares.
- Repurchases may be made on open market or in private transactions under Rule 10b-18.
- Program expected to be completed by December 31, 2025.
- Existing repurchase program expires at end of 2024.
- Repurchase timing and number depend on market conditions.

## SEC filing metadata
- accession: 0000105770-24-000088
- form_type: 8-K
- ticker: WST
- cik: 0000105770
- company_name: WEST PHARMACEUTICAL SERVICES INC
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105770/000010577024000088/0000105770-24-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105770/000010577024000088/wst-20241209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105770-24-000088
- JSON: https://secwatch.observer/filing/0000105770-24-000088.json
- Plain text: https://secwatch.observer/filing/0000105770-24-000088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.